Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The transferrin receptor and the targeted delivery of therapeutic agents against cancer.
Daniels TR, Bernabeu E, Rodríguez JA, Patel S, Kozman M, Chiappetta DA, Holler E, Ljubimova JY, Helguera G, Penichet ML. Daniels TR, et al. Among authors: ljubimova jy. Biochim Biophys Acta. 2012 Mar;1820(3):291-317. doi: 10.1016/j.bbagen.2011.07.016. Epub 2011 Aug 5. Biochim Biophys Acta. 2012. PMID: 21851850 Free PMC article. Review.
Nanoconjugate based on polymalic acid for tumor targeting.
Ljubimova JY, Fujita M, Khazenzon NM, Lee BS, Wachsmann-Hogiu S, Farkas DL, Black KL, Holler E. Ljubimova JY, et al. Chem Biol Interact. 2008 Jan 30;171(2):195-203. doi: 10.1016/j.cbi.2007.01.015. Epub 2007 Feb 8. Chem Biol Interact. 2008. PMID: 17376417 Free PMC article.
Inhibition of brain tumor growth by intravenous poly (β-L-malic acid) nanobioconjugate with pH-dependent drug release [corrected].
Ding H, Inoue S, Ljubimov AV, Patil R, Portilla-Arias J, Hu J, Konda B, Wawrowsky KA, Fujita M, Karabalin N, Sasaki T, Black KL, Holler E, Ljubimova JY. Ding H, et al. Among authors: ljubimova jy. Proc Natl Acad Sci U S A. 2010 Oct 19;107(42):18143-8. doi: 10.1073/pnas.1003919107. Epub 2010 Oct 4. Proc Natl Acad Sci U S A. 2010. PMID: 20921419 Free PMC article.
Polymalic acid-based nanobiopolymer provides efficient systemic breast cancer treatment by inhibiting both HER2/neu receptor synthesis and activity.
Inoue S, Ding H, Portilla-Arias J, Hu J, Konda B, Fujita M, Espinoza A, Suhane S, Riley M, Gates M, Patil R, Penichet ML, Ljubimov AV, Black KL, Holler E, Ljubimova JY. Inoue S, et al. Among authors: ljubimova jy. Cancer Res. 2011 Feb 15;71(4):1454-64. doi: 10.1158/0008-5472.CAN-10-3093. Epub 2011 Feb 8. Cancer Res. 2011. PMID: 21303974 Free PMC article.
75 results